ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,611, issued on June 30, was assigned to IMNEWRUN INC. (Suwon-si, South Korea). "Cell-penetrating peptide and use thereof" was invented by H... Read More
ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,612, issued on June 30, was assigned to ACADEMISCH ZIEKENHUIS LEIDEN (H.O.D.N. LUMC) (Leiden, Netherlands). "Oncolytic non-human adenovirus... Read More
ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,613, issued on June 30, was assigned to Monsanto Technology LLC (St. Louis). "Chimeric insecticidal proteins toxic or inhibitory to lepidop... Read More
ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,614, issued on June 30, was assigned to Nanjing Agricultural University (Nanjing, China). "Use of Glycine max GmSAMMT gene in regulation of... Read More
ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,615, issued on June 30, was assigned to AnserBio Ltd (Nesher, Israel). "Native cell derived vesicles containing tumor suppressor proteins f... Read More
ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,616, issued on June 30, was assigned to The Trustees of the University of Pennsylvania (Philadelphia) and Inovio Pharmaceuticals Inc. (Plymo... Read More
ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,617, issued on June 30, was assigned to RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL (Columbus, Ohio). "Recombinant adeno-associate... Read More
ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,618, issued on June 30, was assigned to SHAANXI UNIVERSITY OF TECHNOLOGY (Hanzhong, China). "Application of MmPI in preparation of trypsin ... Read More
ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,619, issued on June 30, was assigned to Dalichi Sankyo Co. Ltd. (Tokyo). "Method of improving blood kinetics of peptide" was invented by Da... Read More
ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,620, issued on June 30, was assigned to ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (New York). "Neutralizing monoclonal anti-VP1 antibodies to... Read More